TY - JOUR
T1 - Plasma concentrations of arginine vasopressin, oxytocin and angiotensin in patients with hymenoptera venom anaphylaxis
AU - Hermann, Klaus
AU - von Eschenbach, Cordula Ebner
AU - von Tschirschnitz, Marietta
AU - Ring, Johannes
PY - 1993/11/19
Y1 - 1993/11/19
N2 - The plasma concentrations of arginine vasopressin, oxytocin, angiotensin I and II were studied in patients with hymenoptera venom anaphylaxis (n = 50) and healthy volunteers (n = 25). There was no difference in arginine vasopressin: 5.52 ± 0.45 fmol/ml vs. 3.99 ± 0.41 fmol/ml or oxytocin: 28.10 ± 1.13 fmol/ml vs. 26.24 ± 1.80 fmol/ml between patients and controls. No correlation between the severity of clinical symptoms and the plasma levels of arginine vasopressin and oxytocin was found in patients. However, patients with a history of hymenoptera venom anaphylaxis showed significantly reduced angiotensin I and angiotensin II plasma levels as compared to controls (ANG I: 9.51 ± 0.61 fmol/ml vs. 22.91 ± 1.73 fmol/ml; ANG II: 2.84 ± 0.16 fmol/ml vs. 6.95 ± 0.33 fmol/ml. A significant inverse correlation between the severity of clinical symptoms and the plasma levels of angiotensin I and angiotensin II was observed; the lower the concentrations the more severe the clinical symptoms. Oxytocin immunoreactivity eluted from the HPLC column as a single peak with the same retention time as synthetic oxytocin. The vasopressin immunoreactive material could be characterized on HPLC as arginine-vasopressin and two other peptides of unknown nature which crossreacted with the vasopressin antibody. These findings suggest a possible role of angiotensin I and angiotensin II in hymenoptera venom anaphylaxis while arginine vasopressin and oxytocin are most likely not involved.
AB - The plasma concentrations of arginine vasopressin, oxytocin, angiotensin I and II were studied in patients with hymenoptera venom anaphylaxis (n = 50) and healthy volunteers (n = 25). There was no difference in arginine vasopressin: 5.52 ± 0.45 fmol/ml vs. 3.99 ± 0.41 fmol/ml or oxytocin: 28.10 ± 1.13 fmol/ml vs. 26.24 ± 1.80 fmol/ml between patients and controls. No correlation between the severity of clinical symptoms and the plasma levels of arginine vasopressin and oxytocin was found in patients. However, patients with a history of hymenoptera venom anaphylaxis showed significantly reduced angiotensin I and angiotensin II plasma levels as compared to controls (ANG I: 9.51 ± 0.61 fmol/ml vs. 22.91 ± 1.73 fmol/ml; ANG II: 2.84 ± 0.16 fmol/ml vs. 6.95 ± 0.33 fmol/ml. A significant inverse correlation between the severity of clinical symptoms and the plasma levels of angiotensin I and angiotensin II was observed; the lower the concentrations the more severe the clinical symptoms. Oxytocin immunoreactivity eluted from the HPLC column as a single peak with the same retention time as synthetic oxytocin. The vasopressin immunoreactive material could be characterized on HPLC as arginine-vasopressin and two other peptides of unknown nature which crossreacted with the vasopressin antibody. These findings suggest a possible role of angiotensin I and angiotensin II in hymenoptera venom anaphylaxis while arginine vasopressin and oxytocin are most likely not involved.
KW - Angiotensin
KW - Arginine vasopressin
KW - Human
KW - Hymenoptera venom anaphylaxis
KW - Oxytocin
KW - Plasma concentration
UR - http://www.scopus.com/inward/record.url?scp=0027437783&partnerID=8YFLogxK
U2 - 10.1016/0167-0115(93)90377-K
DO - 10.1016/0167-0115(93)90377-K
M3 - Article
C2 - 8278629
AN - SCOPUS:0027437783
SN - 0167-0115
VL - 49
SP - 1
EP - 7
JO - Regulatory Peptides
JF - Regulatory Peptides
IS - 1
ER -